Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH)

American Journal of Hematology

Volumn 53, Issue 1, 1996, Pages 22-29

  Nakakuma, Hideki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

complement regulatory proteins; glycosylphosphatidylinositol anchor; hemolysis; paroxysmal nocturnal hemoglobinuria; PIG A

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN;

COMPLEMENT ACTIVATION; GENE EXPRESSION; HEMOLYSIS; HUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; REVIEW;

HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HUMANS;

EID: 0029829367     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199609)53:1<22::AID-AJH5>3.0.CO;2-7     Document Type: Review

References (71)

1. Rosse WF: Evolution of clinical understanding: Paroxysmal nocturnal hemoglobinuria as a paradigm. Am J Hematol 42:122, 1993.
2. Lee GR: Paroxysmal nocturnal hemoglobinuria. In Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds): "Wintrobe's Clinical Hematology" Ed 9. Vol 1. Philadelphia: Lea & Febiger, 1993, p 1232.
3. Kawahara K, Witherspoon RP, Storb R: Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am J Hematol 39:283, 1992.
4. Rosse WF, Dacie JV: Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest 45:736, 1966.
5. Parker CJ, Baker PJ, Rosse WF: Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 69:337, 1982.
6. Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF: Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 129:184, 1982.
7. Nicholson-Weller A, Spicer DB, Austen KF: Deficiency of the complement regulatory protein, "decay-accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria. N Engl J Med 312:1091, 1985.
8. Medof ME, Kinoshita T, Silber R, Nussetizweig V: Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decayaccelerating factor. Proc Natl Acad Sci USA 82:2980, 1985.
9. Hu VW, Nicholson-Weller A: Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization. Proc Natl Acad Sci USA 82:5520, 1985.
10. Sugita Y, Nakano Y, Tomita M: Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J Biochem 104:633, 1988.
11. Okada N, Harada R, Fujita T, Okada H: A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1:205, 1989.
12. Holguin MH, Fredrick LR, Bernshaw NJ, Wilcox LA, Parker CJ: Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84:7, 1989.
13. Nagakura S, Nakakuma H, Horikawa K, et al.: Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients. Am J Hematol 43:14, 1993.
14. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ: Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192, 1993.
15. Yamashina M, Ueda E, Kinoshita T, et al.: Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 323:1184, 1990.
16. Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF: Identification of human erythrocyte blood group antigens on decay accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 167:1993, 1988.
17. Hänsch GM, Schönermark S, Roelcke D: Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis of C5b-9. J Clin Invest 80:7, 1987.
18. Zalman LS, Wood LM, Frank MM, Müller-Eberhard HJ: Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria. J Exp Med 165:572, 1987.
19. Low MG, Zilversmit DB: Role of phosphatidylinositol in attachment of alkaline phosphatase to membranes. Biochemistry 19:3913, 1980.
20. Roberts WL, Santikarn S, Reinhold VN, Rosenberry TL: Structural characterization of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase by fast atom bombardment mass spectrometry. J Biol Chem 263:18776, 1988.
21. Ferguson MAJ, Williams AF: Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu Rev Biochem 57:285, 1988.
22. Englund PT: The structure and biosynthesis of glycosyl phosphatidyl-inositol protein anchors. Annu Rev Biochem 62:121, 1993.
23. Medof ME, Walter EI, Roberts WL, Haas R, Rosenberry TL: Decay-accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry 25:6740, 1986.
24. van der School CE, Huizinga TWJ, van't Veer-Korthof ET, Wijmans R, Pinkster J, von dem Borne AEGKr: Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 76:1853, 1990.
25. Iwamoto N, Kawaguchi T, Nagakura S, et al.: Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria. Blood 85:2228, 1995.
26. Nakakuma H, Nagakura S, Iwamolo N, et al.: Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia. Blood 85:1371, 1995.
27. Nakakuma H, Kawaguchi T, Horikawa K, et al.: Proposal for a classification of the clinical stages of paroxysmal nocturnal hemoglobinuria. Blood 86:2051, 1995.
28. Stafford HA, Tykocinski ML, Lublin DM, et al.: Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci USA 85:880, 1988.
29. Rambaldi A, Terao M, Bettoni S, et al.: Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes. Blood 73:1113, 1989.
30. Carothers DJ, Hazra SV, Andreson SW, Medof ME: Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes. J Clin Invest 85:47, 1990.
31. Mahoney JF, Urakaze M, Hall S, et al.: Defective glycosylphosphatidyl-inositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes. Blood 79:1400, 1992.
32. Hyman R: Cell-surface-antigen mutants of haematopoietic cells. Tools to study differentiation, biosynthesis and function. Biochem J 225:27, 1985.
33. Stevens VL, Raetz CRH: Defective glycosyl phosphatidylinositol biosynthesis in extracts of three Thy-1 negative lymphoma cell mutants. J Biol Chem 266:10039, 1991.
34. Hidaka M, Nagakura S, Horikawa K, et al.: Impaired glycosylation of glycosylphosphatidylinositol-anchor synthesis in paroxysmal nocturnal hemoglobinuria leukocytes. Biochem Biophys Res Commun 191:571, 1993.
35. Masterson WJ, Doering TL, Hart GW, Englund PT: A novel pathway for glycan assembly: Biosynthesis of the glycosylphosphatidylinositol anchor of the trypanosome variant surface glycoprotein. Cell 56: 793, 1989.
36. Hirose S, Ravi L, Prince GM, et al.: Synthesis of mannosylglucosami-nylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci USA 89:6025, 1992.
37. Hillmen P, Bessler M, Mason PJ, Watkins WM, Luzzatto L: Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 90:5272, 1993.
38. 1 murine lymphoma mutants. J Biol Chem 267:25347, 1992.
39. Takahashi M, Takeda J, Hirose S, et al.: Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 177:517, 1993.
40. Norris J, Sharon H, Ware RE, et al.: Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: Partial or complete defect in an early step. Blood 83:816, 1994.
41. Miyata T, Takeda J, Iida Y, et al.: The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259:1318, 1993.
42. Takeda J, Miyata T, Kawagoe K, et al.: Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703, 1993.
43. Miyata T, Yamada N, Iida Y, et al.: Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 330:249, 1994.
44. Hillmen P, Bessler M, Bungey J, Luzzatto L: Paroxysmal nocturnal hemoglobinuria: Correction of abnormal phenotype by somatic cell hybridization. Somat Cell Mol Genet 19:123, 1993.
45. Bessler M, Mason PJ, Hillmen P, et al.: Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 13:110, 1994.
46. Ware RE, Rosse WF, Howard TA: Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood 83:2418, 1994.
47. Pramoonjago P, Wanachiwanawin W, Chinprasertsak S, Pattanapanayasat K, Takeda J, Kinoshita T: Somatic mutations of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria. Blood 86:1736, 1995.
48. Nafa K, Mason PJ, Hillmen P, Luzzatto L, Bessler M: Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood 86:4650, 1995.
49. Bessler M, Mason P, Hillmen P, Luzzatto L: Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 343:951, 1994.
50. Nakakuma H, Kawaguchi T, Horikawa K, et al.: Altered expression of gangliosides in erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 85:1456, 1990.
51. Parker CJ, Soldato CM, Rosse WF: Abnormality of glycophorin-α on paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest 73:1130, 1984.
52. Judd WJ, Review: Polyagglutination. Immunohematology 8:58, 1992.
53. Horikawa K, Nakakuma H, Nagakura S, et al.: Hemolysis of human erythrocytes is a new bioactivity of gangliosides. J Exp Med 174:1385, 1991.
54. Nakakuma H, Hidaka M, Nagakura S, et al.: Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation. J Clin Invest 96:201, 1995.
55. Dacie J: The auto-immune haemolytic anaemias. In Dacie J (ed): "The Haemolytic Anaemias." Ed 3. Vol 3. Edinburgh: Churchill Livingstone, 1992, pp 1-528.
56. Iwamoto N, Kawaguchi T, Horikawa K, et al.: Haemolysis induced by ascorbic acid in paroxysmal nocturnal hemoglobinuria. Lancet 343:357, 1994.
57. Schubert J, Vogt HG, Zielinska-Skowronek M, et al.: Development of the glycosylphosphatidylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood 83:2323, 1994.
58. Young NS: The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated. Blood 79:1385, 1992.
59. Stafford HA, Nagarajan S, Weinberg JB, Medof ME: PIG-A, DAF and proto-oncogene expression in paroxysmal nocturnal haemoglobinuria-associated acute myelogeneous leukaemia blasts. Br J Haematol 89:72, 1995.
60. Ploug M, Plesner T, Rønne E, et al.: The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood 79:1447, 1992.
61. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM: The monocyte differentiation antigen, CD 14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141:547, 1988.
62. Selvaraj P, Rosse WF, Silber R, Springer TA: The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal hemoglobinuria. Nature 333:565, 1988.
63. Auditore JV, Hartmann RC: Paroxysmal nocturnal hemoglobinuria. II. Erythrocyte acetylcholinesterase defect. Am J Med 27:401, 1959.
64. Beck WS, Valentine WN: Biochemical studies on leucocytes. II. Phosphatase activity in chronic lymphatic leucemia, acute leucemia, and miscellaneous hematologic conditions. J Lab Clin Med 38:245, 1951.
65. Schubert J, Alvarado M, Uciechowski P, et al.: Diagnosis of paroxysmal nocturnal hemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 79:487, 1991.
66. Nagakura S, Kawaguchi T, Horikawa K, et al.: A deficiency in CDw52 (Campath-1 antigen) of paroxysmal nocturnal hemoglobinuria lymphocytes. Blood 82:3790, 1993.
67. Selvaraj P, Dustin ML, Silber R, Low MG, Springer TA: Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor. J Exp Med 166:1011, 1987.
68. Mayne KM, Pulford K, Jones M, et al.: Antibody By114 is selective for the 90 kD PI-linked component of the CD66 antigen: A new reagent for the study of paroxysmal nocturnal haemoglobinuria. Br J Haematol 83:30, 1993.
69. Bobolis KA, Moulds JJ, Telen MJ: Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein. Blood 79:1574, 1992.
70. Antony A: The biological chemistry of folate receptors. Blood 79: 2807, 1992.
71. a/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets. Blood 86:2807, 1995.